Chemical industry – Page 91
-
Business
Reach reviewed: no change required
But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
-
Business
EU proposes neonicotinoid pesticide ban
Clothianidin, thiamethoxam and imidacloprid at centre of debate over declining bee populations
-
Business
Zoetis IPO launches at $2.2bn
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
-
Business
DCD in New Zealand milk
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
-
Business
Unrest over US gas exports
Dow says exports will increase cost of gas and decrease price stability
-
Business
Sabic invests $500m in new R&D centres
Four centres to be created: two in Saudi Arabia, one in India and one in China
-
Opinion
Name reactions: how does the label stick?
Derek Lowe investigates the long running tradition of naming reactions after their inventors
-
Business
Allergan buys MAP for $958m
Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
-
Business
OM Group to exit cobalt business
Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland
-
Business
Vasella to leave Novartis in August
Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
Business
India pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business
UK companies struggling with Reach
Regulation is ‘elephant in the room’ as manufacturers fail to recognise implications
-
Business
Laropiprant recalled
Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
-
Business
Pharma industry 'strategic crisis'
The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
-
Business
Dow Corning to reduce roster by 500
Company says it must respond to oversupplied markets, high raw materials costs and poor growth in many regions
-
Business
EPA focuses on five chemicals
Risk assessments for five chemicals put out for public consultation
-
Business
Illumina investment push
$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests
-
Business
Wellcome Trust launches investment wing
Trust provides £200 million to create Syncona, which will support innovative healthcare businesses